such therapy is likely to be beneficial , particularly since the results of the lipid research clinics primary intervention trial using the bile acid sequestrant , cholestyramine , have demonstrated that lowering ldl-cholesterol levels with this drug also lowers the incidence of coronary heart disease .
C0018799
the
C0018787
heart